Skip to main content
. 2022 Nov 23;10(12):2351. doi: 10.3390/healthcare10122351

Table 6.

Comparative analysis of characteristics information and costs values ($) of two different time periods (in 2019 and in 2020).

Characteristic Year Groups * HD Treatment Cost * Control Cost of HD Patients ** Outpatient Treatment Cost of Catheter Infections ** Inpatient Treatment Cost of Catheter Infections
Mean (95% CI) CV Mean (95% CI) CV Mean (95% CI) CV Mean (95% CI) CV
The time of the diagnosis of ESRD 2019 Cases diagnosed before 2019 5481.7 (5263.8–5699.6) 0.32 671.3 (648.03–694.5) 0.28 60.4 (37.78–83.02) 1.06 427.8 (222.5–633.1) 1.37
Newly diagnosed cases in 2019 2713.4 (2486.2–2940.5) 0.67 450.5 (425.1–475.8) 0.45 42.45 (27.81–57.09) 0.98 56.60 (21.76–91.44) 1.75
p-value 0.000 0.000 0.408 0.007
2020 Cases diagnosed before 2020 4287.8
(4154.8–4420.7)
0.25 523.6 (510.12–537.08) 0.21 57.6 (42.8–72.40) 1.01 152.4 (87.92–216.88) 1.67
Newly diagnosed cases in 2020 2089.0
(1906.0–2272.0)
0.71 317.1 (298.06–336.1) 0.49 48.33 (35.0–61.66) 1.09 64.52 (37.94–91.10) 1.63
p-value ≤0.001 ≤0.001 0.279 0.033

* HD patient number (in 2019 n = 252, in 2020 n = 257); ** patient with catheter infection (in 2019 n = 34, in 2020 n = 63); CV: the variation of coefficient.